Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

View More

Pharmaceutical Published Insights

Coherent Market Insights Antiplatelet Drugs Market

Published Date : Jul 2022

Antiplatelet drugs are prescribed to individuals with a history of heart attacks and these drugs aid in reducing reoccurrence of heart attacks. Some of the antiplatelet medications include, aspirin, clopidogrel, prasugrel, and ticagrelor. Aspirin is recommended for al... View more

Coherent Market Insights Gastroparesis Treatment Market

Published Date : Jul 2022

Gastroparesis is a condition that affects the stomach muscles. It is a disease condition in which the stomach cannot empty itself of food in a normal manner. Nausea, vomiting, heartburn are the symptoms related to gastroparesis. It is most common in patients who have ... View more

Coherent Market Insights Pain Management Drugs Market

Published Date : Jul 2022

Pain management medications are specific drug classes, which have pharmacological actions on pain receptors and work against the pain symptoms. These medications include opioids, non-steroidal anti-inflammatory drugs (NSAIDs), anticonvulsants, antidepressants, muscle ... View more

Coherent Market Insights Us Transthyretin Amyloidosis Treatment Market

Published Date : Jul 2022

Transthyretin amyloidosis is a slowly progressive condition characterized by the buildup of abnormal deposits of a protein called amyloid (amyloidosis) in the body's organs and tissues. Transthyretin amyloidosis (ATTR) is caused by a protein called transthyretin, or T... View more

Coherent Market Insights Foot And Mouth Disease Vaccine Market

Published Date : Jul 2022

Foot and Mouth Disease (FMD) is infectious disease in domestic animals caused due to viral strain Aphtovirus of the family picornaviridae. It majorly affects cloven hooved livestock such as cattle, goat, sheep, swine, and other animals. It can spread through both dire... View more

Coherent Market Insights Scopolamine Market

Published Date : Jul 2022

Scopolamine is an alkaloid drug extracted from a plant called henbane to treat nausea and motion sickness and further to dilate the pupil in ophthalmic procedures. Scopolamine belongs to a class of drugs called anticholinergic. Scopolamine is a tropane alkaloid isolat... View more

Coherent Market Insights Hormone Replacement Therapy Market

Published Date : Jul 2022

Hormone replacement therapy (HRT) can help balance estrogen and progesterone levels during or near menopause. Hormone replacement therapy (HRT) is a treatment to relieve symptoms of menopause. It replaces hormones that are at a lower level as approach the menopause. D... View more

Coherent Market Insights Metabolism Drugs Market

Published Date : Jul 2022

Metabolism functions improperly when enzymes and proteins are either not produced by the body (inherited disorders), or the produced enzymes do not function the way they are meant to. Metabolic disorders occur due to buildup of proteins, lipids, glycogen, urea, calciu... View more

Coherent Market Insights Dementia Drugs Market

Published Date : Jul 2022

Dementia is a form of disease that affects the functioning of the brain resulting in decline in memory or other thinking skills. Alzheimer’s disease is the most common and largest form of dementia (in over 60% cases), which is observed among people aged 65 years... View more

Coherent Market Insights Ear Infection Treatment Market

Published Date : Jul 2022

In an ear infection, narrow tubes that run from the middle ear to high in the back of the throat (eustachian tubes) can become swollen and blocked. Ear infection can affect the inner, middle, and outer layer of the ear. Ear pain and new onset fever after several days ... View more

Coherent Market Insights Cannabis Extract Market

Published Date : Jul 2022

Cannabis is an herbal drug, it has chemicals like cannabinoids, including tetrahydrocannabinol (THC) and cannabidiol (CBD). Cannabis extract can be obtained from any part of the cannabis plant including stems, flowers, and leaves. ... View more

Coherent Market Insights Pulmonary Drugs Market

Published Date : Jul 2022

The pulmonary drugs are used for treating the conditions affecting lungs. The pulmonary drugs are used from treating minor illnesses such as the common cold to cure long-term disorders such asthma. These agents are available in different forms such as oral tablets, or... View more

Coherent Market Insights Hereditary Angioedema Market

Published Date : Jul 2022

Hereditary angioedema (HAE) is characterized by acute skin and mucosal edema caused by an autosomal dominant mutation of the genes. The current treatments of the condition include the HAE drugs which can be administered intravenously, subcutaneously or taken orally. T... View more

Coherent Market Insights Insomnia Therapeutics Market

Published Date : Jul 2022

Insomnia, or sleeplessness, is a sleep disorder in which people have trouble sleeping. Signs and symptoms may include difficulty falling or staying asleep and not feeling well-rested. Sleeping pills may also be used, but should be monitored for side effects. Sometimes... View more

Coherent Market Insights Osteoporosis Treatment Market

Published Date : Jul 2022

Osteoporosis is a bone related disease that weakens bones and increases the risk of fracture and breaking of bones. The factors responsible for osteoporosis include, long-term use of high-dose oral corticosteroids, a family history of osteoporosis – particularly... View more

Coherent Market Insights Crohns Disease Treatment Market

Published Date : Jul 2022

Crohn’s disease is a form of chronic inflammatory bowel disease (IBD) that causes inflammation in the gastrointestinal tract. This inflammation can take place anywhere between the ileum of the small inte... View more

Coherent Market Insights Adult Vaccines Market

Published Date : Jul 2022

Vaccines refer to the biological preparation that improves immunity to fight against a particular disease. Vaccines comprise suspensions formulated from weakened, killed or fragmented microorganisms, toxins or antibodies that are administered to a patient, with a prim... View more

Coherent Market Insights Cannabis Testing Services Market

Published Date : Jul 2022

Cannabis, often known as marijuana, is a psychoactive substance derived from the cannabis plant. The major psychoactive component of cannabis is tetrahydrocannabinol (THC). Cannabis can be consumed via smoking, vaporizing, ingesting, or consuming it as an extract. Ove... View more

Coherent Market Insights Local Anesthesia Drugs Market

Published Date : Jun 2022

Local anaesthesia involves numbing an area of the body using a type of medicine called a local anaesthetic. It is a type of pain control used during minor procedures to numb small area where the pain is likely to occur. The use of long-acting local anesthetic prolongs... View more

Coherent Market Insights Gel Permeation Chromatography Market

Published Date : Jun 2022

Gel permeation chromatography is a size exclusion technique used for separation and characterization of polymers. It is an exclusive technique to perform polymer characterization, in order to assess the molecular weight distribution of an analyte. Profiling of the pol... View more

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.